Leukaemia (lymphocytic) - fludarabine
Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia
Summary
Fludarabine given on its own is not recommended as an initial treatment for people with chronic lymphocytic leukaemia (CLL). Fludarabine is not licensed to be prescribed for CLL in combination with other chemotherapy medicines. This is because its 'marketing authorisation', which is normally needed ...
Guidance documents
Implementing this guidance
Other information
We will consult on our review plans for this guidance in October 2009
About this guidance
Technology appraisals TA119
Issued: February 2007
How this guidance was produced